AFIB · As filed with the SEC
Acutus Medical balance sheet, by quarter
The statement as Acutus Medical presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Balance Sheets · USD thousands
| USD thousands | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | 14,019 | 12,595 | 13,327 | 18,459 | 19,170 | 24,100 | 23,055 | 22,738 |
| Marketable securities, short-term | 0 | 0 | 0 | 1,495 | 3,233 | 14,375 | 31,461 | 46,839 |
| Restricted cash, short-term | 0 | 0 | 0 | 0 | 7,030 | 7,015 | 7,002 | 7,139 |
| Accounts receivable | 7,878 | 9,970 | 9,235 | 7,750 | 11,353 | 8,952 | 7,670 | 5,340 |
| Inventory | 1,790 | 4,191 | 5,213 | 5,888 | 4,278 | 15,728 | 15,671 | 14,938 |
| Employer retention credit receivable | — | — | — | — | 0 | 0 | 0 | 2,562 |
| Prepaid expenses and other current assets | 641 | 403 | 507 | 572 | 678 | 2,467 | 2,444 | 2,232 |
| Current assets of discontinued operations (Note 3) | 1,250 | 0 | 175 | 240 | 510 | — | — | — |
| Total current assets | 25,578 | 27,159 | 28,457 | 34,404 | 46,252 | 72,637 | 87,303 | 101,788 |
| Noncurrent assets | ||||||||
| Property and equipment, net | 517 | 736 | 808 | 844 | 825 | 6,611 | 7,245 | 8,145 |
| Right-of-use assets, net | 2,459 | 2,647 | 2,831 | 3,011 | 3,189 | 3,359 | 3,533 | 3,708 |
| Intangible assets, net | — | — | — | — | — | 1,433 | 1,483 | 1,533 |
| Other assets | 94 | 94 | 94 | 94 | 94 | 688 | 731 | 822 |
| Non-current assets of discontinued operations (Note 3) | 0 | 1,531 | 3,284 | 3,315 | 3,600 | — | — | — |
| Total assets | 28,648 | 32,167 | 35,474 | 41,668 | 53,960 | 84,728 | 100,295 | 115,996 |
| LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | 1,276 | 1,711 | 1,683 | 3,165 | 2,761 | 4,754 | 5,492 | 5,569 |
| Accrued liabilities | 3,006 | 1,702 | 1,609 | 2,063 | 2,887 | 7,438 | 9,759 | 7,302 |
| Contingent consideration, short-term | — | — | — | — | — | — | 0 | 2,000 |
| Contingent consideration, short-term | — | — | — | — | 0 | 0 | — | — |
| Operating lease liabilities, short-term | 957 | 897 | 886 | 835 | 718 | 707 | 466 | 339 |
| Long-term debt, current portion | 7,005 | 7,084 | 7,055 | 1,819 | 1,864 | — | — | — |
| Warrant liability | 194 | 302 | 128 | 692 | 409 | 1,868 | 2,504 | 1,900 |
| Current liabilities of discontinued operations (Note 3) | 0 | 2,969 | 1,017 | 1,300 | 10,303 | — | — | — |
| Total current liabilities | 12,438 | 14,665 | 12,378 | 9,874 | 18,942 | 14,767 | 18,221 | 17,110 |
| Operating lease liabilities, long-term | 2,238 | 2,532 | 2,771 | 3,009 | 3,243 | 3,462 | 3,679 | 3,883 |
| Long-term debt | 25,564 | 25,269 | 25,130 | 32,805 | 32,654 | 34,761 | 34,634 | 34,526 |
| Other long-term liabilities | — | — | — | — | 0 | 32 | 20 | 11 |
| Total liabilities | 40,240 | 42,466 | 40,279 | 45,688 | 54,839 | 53,022 | 56,554 | 55,530 |
| Stockholders' (deficit) equity | ||||||||
| Preferred stock, $0.001 par value; 5,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 6,666 shares of the preferred stock, designated as Series A Common Equivalent Preferred Stock, are issued and outstanding as of December 31, 2024 and December 31, 2023, respectively | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common stock, $0.001 par value; 260,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 29,912,305 and 29,313,667 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively | 30 | 30 | 30 | 30 | 29 | 29 | 29 | 29 |
| Additional paid-in capital | 598,670 | 598,670 | 598,542 | 598,413 | 599,935 | 598,842 | 597,578 | 595,864 |
| Accumulated deficit | (609,524) | (608,118) | (602,511) | (601,597) | (599,977) | (566,212) | (552,975) | (534,629) |
| Accumulated other comprehensive loss | (768) | (881) | (866) | (866) | (866) | (953) | (891) | (798) |
| Total stockholders' equity | — | — | — | — | — | 31,706 | 43,741 | 60,466 |
| Total stockholders' deficit | (11,592) | (10,299) | (4,805) | (4,020) | (879) | — | — | — |
| Total liabilities and stockholders' deficit | 28,648 | 32,167 | 35,474 | 41,668 | 53,960 | 84,728 | 100,295 | 115,996 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.
Data on this page was fetched . The filing on SEC.gov is the record.